Shorter Disease Duration Predicts Earlier Complete Skin Clearance in Biologic-naïve Psoriasis Treated with Biologics

The association between psoriasis disease duration and complete skin clearance after biologic initiation remains uncertain. This single-centre retrospective study included 218 biologic-naïve patients who initiated biologic therapy between 2010 and 2024. Disease duration was defined as the interval from symptom onset to biologic initiation and categorized as ≤2 years or >2 years. Absolute Psoriasis Area and Severity Index (PASI) 0 was assessed at 3 months, 6 months, 1 year and 2 years using an as-observed approach. Twenty-nine patients (13.3%) had disease duration ≤2 years. At 3 months, absolute PASI 0 was achieved in 6/29 (20.7%) patients with shorter disease duration and 14/189 (7.4%) with longer disease duration (p=0.033). No significant differences were detected at subsequent assessments. In an exploratory multivariable Cox model including baseline PASI, shorter disease duration was associated with early PASI 0 achievement (hazard ratio 4.75; 95% confidence interval 1.57-14.40). Sparse early events and incomplete covariate data limit interpretation. Shorter disease duration was associated with earlier complete skin clearance; larger studies are needed to establish whether this association is independent of treatment selection and other confounders.

Authors

Institutions

Publication Details

Journal
Acta Dermato Venereologica
Published
2026-11-18
DOI
https://doi.org/10.2340/actadv.v106.adv-2026-0697
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Shorter Disease Duration Predicts Earlier Complete Skin Clearance in Biologic-naïve Psoriasis Treated with Biologics

Masahiro Kamata, Itsumi Mizukawa, Azusa Hiura, Ryosuke Takeshima et al.
2 links
Acta Dermato Venereologica
Psoriasis: Treatment and Pathogenesis
article

Shorter Disease Duration Predicts Earlier Complete Skin Clearance in Biologic-naïve Psoriasis Treated with Biologics

Masahiro Kamata, Itsumi Mizukawa, Azusa Hiura, Ryosuke Takeshima, Ayu Watanabe, Kotaro Hayashi, Shoya Suzuki, Chika Chijiwa, Yoshiki Okada, Yoshitsugu KUBO
article en

Abstract

The association between psoriasis disease duration and complete skin clearance after biologic initiation remains uncertain. This single-centre retrospective study included 218 biologic-naïve patients who initiated biologic therapy between 2010 and 2024. Disease duration was defined as the interval from symptom onset to biologic initiation and categorized as ≤2 years or >2 years. Absolute Psoriasis Area and Severity Index (PASI) 0 was assessed at 3 months, 6 months, 1 year and 2 years using an as-observed approach. Twenty-nine patients (13.3%) had disease duration ≤2 years. At 3 months, absolute PASI 0 was achieved in 6/29 (20.7%) patients with shorter disease duration and 14/189 (7.4%) with longer disease duration (p=0.033). No significant differences were detected at subsequent assessments. In an exploratory multivariable Cox model including baseline PASI, shorter disease duration was associated with early PASI 0 achievement (hazard ratio 4.75; 95% confidence interval 1.57-14.40). Sparse early events and incomplete covariate data limit interpretation. Shorter disease duration was associated with earlier complete skin clearance; larger studies are needed to establish whether this association is independent of treatment selection and other confounders.

Acta Dermato VenereologicaVol. 106
Teikyo University (JP)
Good health and well-being
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon